January 21, 2026
Health Canada is warning consumers of counterfeit versions of Ozempic and Mounjaro being sold in various retailers nationwide.
In a public advisory posted Thursday, the health agency said unauthorized versions of GLP-1 products like semaglutide, which include the widely-known drugs Ozempic, Rybelsus and Wegovy, are being sold in stores and online.
“Some websites and social media advertisements misuse official Health Canada logos and display fake endorsements to mislead consumers,” it warned.
Health Canada advised that these type of unauthorized products can pose serious health risks because the health agency has not assessed it for “safety, effectiveness, or quality.”
The popularity in these drugs have skyrocketed in recent years, as they mimic GLP-1, a natural hormone in the body, which helps treat people with Type 2 diabetes, manage blood sugar levels and treat obesity.